BHVN
Price:
$13.89
Market Cap:
$2.09B
Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA nephropathy; BHV-1600, which is in Phase 1 clinical trial for the treatment of peripartum cardiomyopathy; BHV-8000 that is in Phase 3 clinical trial for treating Parkinson's disease; Opakalim, which is in Phase 3 clinical trial for the treatment of focal epilepsy; BHV-2100 that is in Phase 2 clinical trial for the treatment of pain disorde...[Read more]
Industry
Biotechnology
IPO Date
2022-09-23
Stock Exchange
NYSE
Ticker
BHVN
According to Biohaven Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.15B. This represents a change of 28.54% compared to the average of 1.67B of the last 4 quarters.
The mean historical Enterprise Value of Biohaven Ltd. over the last ten years is 891.59M. The current 2.15B Enterprise Value has changed 24.02% with respect to the historical average. Over the past ten years (40 quarters), BHVN's Enterprise Value was at its highest in in the September 2024 quarter at 4.66B. The Enterprise Value was at its lowest in in the December 2018 quarter at -146734000.00.
Average
891.59M
Median
188.25M
Minimum
-146734000.00
Maximum
3.35B
Discovering the peaks and valleys of Biohaven Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 529.24%
Maximum Annual Enterprise Value = 3.35B
Minimum Annual Increase = -125.39%
Minimum Annual Enterprise Value = -146734000.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.27B | -62.04% |
| 2024 | 3.35B | 18.20% |
| 2023 | 2.83B | 529.24% |
| 2022 | 449.73M | 138.90% |
| 2021 | 188.25M | 3.09% |
| 2020 | 182.61M | 390.22% |
| 2019 | 37.25M | -125.39% |
| 2018 | -146734000.00 | 11.61% |
The current Enterprise Value of Biohaven Ltd. (BHVN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.48B
5-year avg
1.62B
10-year avg
891.59M
Biohaven Ltd.’s Enterprise Value is greater than Intellia Therapeutics, Inc. (1.68B), greater than Immunome, Inc. (2.07B), less than AbCellera Biologics Inc. (3.90B), less than Vera Therapeutics, Inc. (2.49B), less than Zenas BioPharma, Inc. (2.21B), less than Celldex Therapeutics, Inc. (2.55B), greater than Pharvaris N.V. (1.99B), greater than Xeris Biopharma Holdings, Inc. (1.58B), greater than Sionna Therapeutics, Inc. (268.93M), greater than Immunocore Holdings plc (1.59B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.68B | $1.71B | |
| 2.07B | $2.29B | |
| 3.90B | $3.89B | |
| 2.49B | $2.46B | |
| 2.21B | $2.02B | |
| 2.55B | $2.59B | |
| 1.99B | $2.66B | |
| 1.58B | $1.41B | |
| 268.93M | $324.18M | |
| 1.59B | $1.64B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biohaven Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biohaven Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Biohaven Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Biohaven Ltd. (BHVN)?
What is the 3-year average Enterprise Value for Biohaven Ltd. (BHVN)?
What is the 5-year average Enterprise Value for Biohaven Ltd. (BHVN)?
How does the current Enterprise Value for Biohaven Ltd. (BHVN) compare to its historical average?